<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">

<channel>
<title><![CDATA[Chugai Pharmaceutical: News Releases]]></title>
<link>https://www.chugai-pharm.co.jp/english/index.html</link>
<description><![CDATA[News Releases]]></description>
<category><![CDATA[News Releases]]></category>
<language>en-us</language>
<copyright><![CDATA[Copyright(C) Chugai Pharmacetical Co.,Ltd. All rights reserved.]]></copyright>
<lastBuildDate>Tue, 26 May 2026 11:30:00 +0900</lastBuildDate>

<item>
<title><![CDATA[Chugai Receives &#8220;The Imperial Invention Prize,&#8221; the Highest Honor of the FY2026 National Commendation for Invention — Recycling Antibody Technology Recognized for its Contribution to Pharmaceutical Research —]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260526113000_1253.html</link>
<description></description>
<category></category>
<pubDate>Tue, 26 May 2026 11:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260526113000_1253.html</guid>
</item>
<item>
<title><![CDATA[Organizational and Personnel Changes]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260525153000_1252.html</link>
<description></description>
<category></category>
<pubDate>Mon, 25 May 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260525153000_1252.html</guid>
</item>
<item>
<title><![CDATA[Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic of Alecensa for ALK Fusion Gene-Positive Solid Tumors]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260518153000_1244.html</link>
<description></description>
<category></category>
<pubDate>Mon, 18 May 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260518153000_1244.html</guid>
</item>
<item>
<title><![CDATA[Alecensa Receives the World-First Tumor-Agnostic Approval for ALK Fusion Gene-Positive Solid Tumors Across Adult and Pediatric Patients]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260518153001_1249.html</link>
<description></description>
<category></category>
<pubDate>Mon, 18 May 2026 15:30:01 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260518153001_1249.html</guid>
</item>
<item>
<title><![CDATA[Filing of Humanized Anti-CD20 Monoclonal Antibody Gazyva for Additional Indication of Idiopathic Nephrotic Syndrome]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260514153000_1250.html</link>
<description></description>
<category></category>
<pubDate>Thu, 14 May 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260514153000_1250.html</guid>
</item>
<item>
<title><![CDATA[Chugai&rsquo;s Pharmaceutical Packaging Leveraging Proprietary Technologies Wins the &ldquo;WorldStar Winner 2026&rdquo; at the &ldquo;WorldStar Global Packaging Awards 2026&rdquo; from the World Packaging Organization]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260511153000_1251.html</link>
<description></description>
<category></category>
<pubDate>Mon, 11 May 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260511153000_1251.html</guid>
</item>

</channel>
</rss>
